Results 171 to 180 of about 910,008 (206)
Search for diboson resonances with boson-tagged jets in ppcollisions at √s=13TeVwith the ATLAS detector [PDF]
ATLAS Collaboration +10 more
core +1 more source
Advances in cholangiocarcinoma research: Report from the third Cholangiocarcinoma Foundation Annual Conference [PDF]
Chapman, William, et al,
core +1 more source
Durable Response in <i>NTRK</i> Fusion-Positive Advanced Salivary Gland Tumor: A Case Report. [PDF]
Oblitas Alca GA +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Novel fusion sarcomas including targetable NTRK and ALK
Annals of Diagnostic Pathology, 2021Challenging emerging entities with distinctive molecular signatures may benefit from algorithms for diagnostic work-up.Fusion sarcomas (2020-2021, during pandemic) were diagnosed by clinicoradiology, morphology, phenotype, and next-generation sequencing (NGS).Six fusion sarcomas in two males and four females involved the chest-wall, neck, or ...
Tiane, Chen +9 more
openaire +2 more sources
[NTRK Gene Fusions and Treatment in NTRK Fusion-Positive Solid Cancers].
Gan to kagaku ryoho. Cancer & chemotherapy, 2022Neurotrophic tyrosine receptor kinase(NTRK)gene variants have been reported in a variety of cancer types. The prevalence of NTRK gene variants is less than 1% in many types of solid cancer. The highest NTRK gene fusions frequencies were found in secretary breast carcinoma and infantile fibrosarcoma.
Misao, Fukuda, Yoichi, Naito
openaire +1 more source
NTRK-Fusions – A new kid on the block
Pathology - Research and Practice, 2019The neurotrophic tyrosine receptor kinases (NTRK) play an important role in the development and function of the nervous system. Fusions involving NTRK and a wide range of genes that act as fusion partners are oncogenic and activate well-known signal transduction pathways like the MAPK-ERK pathway.
Märkl, Bruno +2 more
openaire +2 more sources
NTRK fusions in lung cancer: From biology to therapy
Lung Cancer, 2021Fusions involving TRK protein tyrosine kinases are oncogenic drivers in a variety of tumors in children and adults, with a prevalence of ∼0.2% in non-small cell lung cancer. Diagnosis can be challenging due to structural features such as NTRK intron length, but next-generation sequencing (NGS), including RNA-based NGS, increases detection.
Guilherme Harada +3 more
openaire +2 more sources

